VYGR
VYGR
NASDAQ · Biotechnology

Voyager Therapeutics Inc

$3.77
-0.48 (-11.20%)
As of May 16, 2:05 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,133.5% upside
Low Target $29.94
Average Target $46.44
High Target $64.67
Current Price $3.77
Current
$3.77
Target
$46.44
$29.94 $46.44 avg $64.67
Scenario Analysis
Bear Case
$29.94
695.2%
Low target
Base Case
$46.44
+1,133.5%
Avg target
Bull Case
$64.67
+1,617.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.55
-32.2% from high
52-Week Low
$2.65
+42.3% from low
Target vs 52W High
$46.44
+736.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%